Update on cognitive decline and dementia in elderly patients with diabetes

Diabetes and Metabolism

Volumn 40, Issue 5, 2014, Pages 331-337

  Bordier, L ^a   Doucet, J ^b   Boudet, J ^c   Bauduceau, B ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c Lilly France   (France)

Author keywords

Cognitive impairment; Dementia; Diabetes; Elderly patient; Hypoglycaemia

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

AGED; ALZHEIMER DISEASE; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIABETIC PATIENT; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; GLUCOTOXICITY; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INCIDENCE; LIFE EXPECTANCY; LONGEVITY; LONGITUDINAL STUDY; MEDICAL HISTORY; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT AUTONOMY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK FACTOR; BLOOD; CEREBROVASCULAR DISORDERS; CHEMICALLY INDUCED; COGNITION DISORDERS; COMPLICATION; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; METABOLISM; PATIENT EDUCATION; PREVALENCE; PSYCHOLOGY; SELF CARE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEMENTIA; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LONGITUDINAL STUDIES; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; PREVALENCE; RISK FACTORS; SELF CARE;

EID: 84908504599     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.02.002     Document Type: Review

References (46)

1. Fagot-Campagna A., Romon I., Fosse S., Roudier C., Institut de veille sanitaire Prévalence et incidence du diabète, et mortalité liée au diabète en France. Synthèse épidémiologique 2010, InVS, 12p.
2. Ramaroson H., Helmer C., Barberger-Gateau P., Letenneur L., Dartigues J.F. PAQUID. Prevalence of dementia and Alzheimer's disease among subjects aged 75years or over: updated results of the PAQUID cohort. Rev Neurol 2003, 159:405-411.
3. Doucet J., Le Floch J.P., Bauduceau B., Verny C., The SFD/SFGG Intergroup GERODIAB: Glycaemic control and 5-year morbidity/mortality of type2 diabetic patients aged 70years and older: 1. Description of the population at inclusion. Diabetes Metab 2012, 38:523-530.
4. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005, 48:2460-2469.
5. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4:e4144.
6. Yaffe K., Fiocco A.J., Lindquist K., Vittinghoff E., Simonsick E.M., Newman A.B., et al. Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology 2009, 72:2029-2035.
7. Comijs H.C., Kriegsman D.M., Dik M.G., Deeg D.J., Jonker C., Stalman W.A. Somatic chronic diseases and 6-year change in cognitive functioning among older persons. Arch Gerontol Geriatr 2009, 48:191-196.
8. Knopman D.S., Mosley T.H., Catellier D.J., Coker L.H. Atherosclerosis risk in communities study brain MRI study. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 2009, 5:207-214.
9. Christman A.L., Matsumita K., Gottesman R.F., Mosley T., Alonso A., Coresh J., et al. Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2011, 54:1645-1652.
10. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental-State. A practical method for grading the cognitive state on patients for the clinician. J Psychiatr Res 1975, 12:189-198.
11. Artero S., Ancelin M.L., Portet F., Dupuy A., Berr C., Dartigues J.F., et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008, 79:979-984.
12. Xu W., Caracciolo B., Wang H.X., Winblad B., Backman L., Qiu C., et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 2010, 59:2928-2935.
13. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004, 256:240-246.
14. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
15. Irie F., Fitzpatrick A.L., Lopez O.L., Kuller L.H., Peila R., Newman A.B., et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study. Cognition Study. Arch Neurol 2008, 65:89-93.
16. Luchsinger J.A., Palmas W., Teresi J.A., Silver S., Kong J., Eimikcke J., et al. Improved diabetes control in elderly delays global cognitive decline. J Nutr Health Aging 2012, 15:445-449.
17. Shorr R.I., de Rekeneire N., Resnick H.E., Yaffe K., Somes G.W., Kanaya A.M., et al. Glycaemia and cognitive function in older adults using glucose-lowering drugs. J Nutr Health Aging 2006, 10:297-301.
18. Yaffe K., Falvey C., Hamilton N., Schwartz A.V., Simonsick E.M., Satterfield S., et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012, 69:1170-1175.
19. Ryan C.M., Freed M.I., Rood J.A., Cobitz A.R., Waterhouse B.R., Strachan M.W. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006, 29:345-351.
20. Cukierman-Yaffe T., Gerstein H.C., Williamson J.D., Lazar R.M., Lovato L., Miller M.E., et al. Relationship between baseline glycaemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009, 32:221-226.
21. Launer L.J., Miller M.E., Willimason J.D., Lazar R.M., Gerstein H.C., Murray A.M., et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomized open-label study. Lancet Neurol 2001, 10:969-977.
22. Aung P.P., Strachan M.W., Frier B.M., Butcher I., Deary I.J., Price J.F. Edinburgh Type 2 severe hypoglycaemia and late-life cognitive ability in older people with type 2 diabetes: the Edinburgh Type 2 diabetes study. Diabetes Med 2012, 29:328-336.
23. Whitmer R.A., Karter A.J., Yaffe K., Quesenberry C.P., Selby J.V. Hypoglycaemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
24. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356:1842-1852.
25. de Galan B.E., Zoungas S., Chalmers J., Anderson C., Dufouil C., Pillai A., et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009, 52:2328-2336.
26. Punthakee Z., Miller M.E., Launer L.J., Williamson J.D., Lazar R.M., Cukierman-Yaffee T., et al. Poor cognitive function and risk of severe hypoglycaemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012, 35:787-793.
27. Feil D.G., Rajan M., Soroka O., Tseng C.L., Miller D.R., Pogach L.M. Risk of hypoglycaemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc 2011, 59:2263-2272.
28. Bruce D.G., Davis W.A., Casey G.P., Clarnette R.M., Brown S.G., Jacobs I.G., et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 2009, 52:1808-1815.
29. Strachan M.W., Reynolds R.M., Marioni R.E., Price J.F. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 2011, 7:108-114.
30. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:2672-2713.
31. Luchsinger J.A. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis 2012, 30:S185-S198.
32. Yaffe K., Lindquist K., Schwartz A.V., Vitartas C., Vittinghoff E., Satterfield S., et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 2011, 7:1351-1356.
33. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007, 4:147-152.
34. McNay E.C., Cotero V.E. Mini-review: impact of recurrent hypoglycaemia on cognitive and brain function. Physiol Behav 2010, 100:234-238.
35. Vischer U.M., Bauduceau B., Bourdel-Marchasson I., Blickle J.F., Constans T., Fagot-Campagna A., et al. SFGG French-speaking group for study of diabetes in the elderly. A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes Metab 2009, 35:168-177.
36. McGuire L.C., Ford E.S., Ajani U.A. The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging. BMC Geriatr 2006, 6:8.
37. Maraldi C., Volpato S., Penninx B.W., Yaffe K., Simonsick E.M., Strotmeyer E.S., et al. Diabetes mellitus, glycaemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med 2007, 167:1137-1144.
38. Munshi M., Grande L., Hayes M., Ayres D., Suhl E., Capelson R., et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006, 29:1794-1799.
39. Sinclair A., Morley J.E., Rodriguez-Manas L., Paolisso G., Bayer T., Zyfang A., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP) and the International task force of experts in diabetes. JAMDA 2012, 13:497-502.
40. Sinclair A.J., Paolisso G., Castro M., Bourdel-Marchasson I., Gadsby R., Rodriguez Mañas L. European Diabetes Working Party for Older People. Clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011, 37(Suppl.3):S27-S38.
41. Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012, 55:1577-1596.
42. Haute Autorité de santé Stratégie médicamenteuse du contrÔle glycémique du diabète de type 2. Recommandations de bonne pratique 2013, 331p.
43. Kirkman M.S., Briscoe V.J., Clark N., Florez H., Haas L.B., Halter J.B., et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc 2012, 60:2342-2356.
44. Derouesné C., Poitreneau J., Hugonot L., Kalafat M., Dubois B., Laurent B. Le Mini-Mental State Examination (MMSE): un outil pratique pour l'évaluation de l'état cognitif des patients par le clinicien. Version française consensuelle. Presse Med 1999, 21:1141-1148.
45. Haute Autorité de santé Réévaluation des médicaments indiqués dans le traitement de la maladie d'Alzheimer 2011, 72p.
46. Braun A.K., Kubiak T., Kuntsche J., Meier-Hofig M., Muller U.A., Feucht I., et al. SGS: a structured treatment and teaching programme for older patients with diabetes mellitus - a prospective randomized controlled multi-centre trial. Age Ageing 2009, 38:390-396.